ArticlePharmaceuticals (Basel, Switzerland)2022

Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control Study.

Maria Albanese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.